A new clinical guideline from the American Society for Radiation Oncology (ASTRO) recommends shorter courses of radiation ...
The update replaces ASTRO’s 2018 recommendations to reflect the growing body of evidence showing that hypofractionated ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
A new ASTRO clinical guideline recommends moderately shortened radiation schedules for all risk groups of localized prostate ...
University Hospitals research suggests the Decipher tumor score could help doctors personalize treatment decisions for men ...
A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for ...
For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...
What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...
Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...
ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST Darolutamide plus ADT and radiation therapy reduces risk of metastasis or ...
Over the last 15 years, low-risk prostate cancer has become less common at diagnosis and is increasingly managed through active surveillance, according to research published in Ca ...
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results